China is ramping up its manufacturing of medical goods, including masks, PPE, and ventilators, as it seeks to ship them off to other countries in desperate need of supply. Though China was once the epicenter of the COVID-19 outbreak, it has become one of the first countries to successfully contain the virus and is looking to capitalize on the returning strength of their manufacturing workforce. The latest rolling back of regulatory restrictions on healthcare exports will put Chinese firms in an even better position to scale up their output in coming months as foreign markets begin stocking up for Coronavirus’ “second wave” next fall.
Related ETF: KraneShares MSCI All China Health Care Index ETF (KURE)
To read this Market Insight, you’ll need to sign in
If you don’t have a subscription, sign up or start a free trial .